HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements
about
Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy.A 72-hour high fat diet increases transcript levels of the neuropeptide galanin in the dorsal hippocampus of the rat.Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinomaEpigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia.Melatonin and sirtuins: A "not-so unexpected" relationship.Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.Huntington's disease is a multi-system disorder.Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors.A shared mechanism of muscle wasting in cancer and Huntington's disease.Site Specific Modification of Adeno-Associated Virus Enables Both Fluorescent Imaging of Viral Particles and Characterization of the Capsid Interactome.The mechanism and potential targets of class II HDACs in angiogenesis.A Fluorescence-Lifetime-Based Binding Assay for Class IIa Histone Deacetylases.Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson's Disease.Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons.Neuro-Cardio Mechanisms in Huntington's Disease and Other Neurodegenerative Disorders.Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
P2860
Q33853732-4D888966-4CF1-47CC-BB91-DB2BC04C19A5Q35741908-0936F7F7-7B63-479D-A104-C72FD7D7DEA6Q37062452-E931A04C-1139-4D0B-BF5E-9255ACB1136FQ38743021-71D673B5-3370-45D3-B8EE-9376A0C4BA9FQ39008527-F897DF76-64D2-4062-A93C-99DC82CD55D1Q39636313-28CAB298-417B-4530-A5A5-3D69DB4C9AB8Q41597422-B0986ACA-C97C-41A4-AF0A-E01EFE676215Q43083918-F27E2413-896A-42F6-A2DE-4DB8A79C6073Q43131306-AA30F544-2266-450E-889A-156F44B24C4CQ45325135-70264F34-C602-4C05-85ED-6B94BCFBE15DQ47865822-36835619-8AF2-49F4-B33F-13BDD587CD71Q48178633-77BE7B3E-3782-4BB7-BD30-BDB43962A454Q48456357-6120299F-3644-4D6C-80E0-BDCF1B5CAB9FQ48895841-A4ED96A1-D9EF-499F-AE3B-ABDB0DF55E49Q54979284-3565776A-BB07-4270-9F90-F26ED51A9CBEQ58699639-85E7C15D-E381-469A-9A0C-60396A8A58B8
P2860
HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
HDAC4 as a potential therapeut ...... summary of recent achievements
@en
type
label
HDAC4 as a potential therapeut ...... summary of recent achievements
@en
prefLabel
HDAC4 as a potential therapeut ...... summary of recent achievements
@en
P2860
P50
P356
P1476
HDAC4 as a potential therapeut ...... summary of recent achievements
@en
P2093
Alisia Carnemolla
P2860
P356
10.3389/FNCEL.2015.00042
P577
2015-02-24T00:00:00Z